Imatinib mesylate inhibits CD4+CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumors

  • Nicolas Larmonier
  • , Nona Janikashvili
  • , Collin James Lacasse
  • , Claire Billerey Larmonier
  • , Jessica Cantrell
  • , Elaine Situ
  • , Tamara Lundeen
  • , Bernard Bonnotte
  • , Emmanuel Katsanis

Research output: Contribution to journal › Article › peer-review

157   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib mesylate inhibits CD4+CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumors'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science